Sign In
Buy AMPE
$0.183
+0 (+0%)
At Close: Jun 03, 2026
ENGLEWOOD, Colo., Sept. 15, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent infla
Ampio Pharmaceuticals Announces Important New Research Manuscript on Anti-Inflammatory Mode of Action
09:15am, Friday, 13'th Aug 2021
ENGLEWOOD, Colo., Aug. 13, 2021 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent in
Ampio Pharmaceuticals Reminds Stockholders to Vote Shares in Advance of 2021 Annual Meeting
09:15am, Thursday, 12'th Aug 2021
ENGLEWOOD, Colo., Aug. 12, 2021 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent in
Ampio Pharmaceuticals to Participate in Upcoming Virtual Investor Conferences
09:15am, Wednesday, 11'th Aug 2021
ENGLEWOOD, Colo., Aug. 11, 2021 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent
Why Penny Stocks Investors Are Bullish on These 3 Small-Caps
05:13pm, Thursday, 05'th Aug 2021
Why penny stocks investors are showing bullish interest in these 3 small-caps The post Why Penny Stocks Investors Are Bullish on These 3 Small-Caps appeared first on Penny Stocks to Buy, Picks, News a
Here's Why Ampio Pharmaceuticals Stock Is Surging Today
01:24pm, Thursday, 05'th Aug 2021
A positive second-quarter earnings report and anticipation of further details to be discussed this afternoon helped this beaten-down biotech stock recover some previous losses.
Ampio Pharmaceuticals, Inc. (AMPE) CEO Mike Macaluso on Q2 2021 Results - Earnings Call Transcript
07:18pm, Wednesday, 04'th Aug 2021
Ampio Pharmaceuticals, Inc. (AMPE) CEO Mike Macaluso on Q2 2021 Results - Earnings Call Transcript
Ampio Pharmaceuticals to Present at the American College of Toxicology 42nd Annual Meeting
09:15am, Thursday, 29'th Jul 2021
ENGLEWOOD, Colo., July 29, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent infl
ENGLEWOOD, Colo., July 28, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent infl
Ampio Pharmaceuticals to Present at Aspen Lung Conference
09:15am, Tuesday, 27'th Jul 2021
ENGLEWOOD, Colo., July 27, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent infl
Ampio Pharmaceuticals, Inc. to Report Fiscal 2021 Second Quarter Financial Results and Provide Corporate Business Update
09:15am, Wednesday, 14'th Jul 2021
ENGLEWOOD, Colo., July 14, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflamm
Best Biotech Penny Stocks In Summer 2021? 7 For Your Watchlist
04:05pm, Thursday, 01'st Jul 2021
Are these the best biotech penny stocks to watch right now? The post Best Biotech Penny Stocks In Summer 2021?
ENGLEWOOD, Colo., June 25, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent infl
Ampio Pharmaceuticals, Inc. to Join the Russell 2000® Index and Russell 3000® Index
09:15am, Friday, 18'th Jun 2021
ENGLEWOOD, Colo., June 18, 2021 /PRNewswire/ – Ampio Pharmaceuticals (NYSE American: AMPE), a clinical stage biopharmaceutical company focused on the advancement of immunology-based therapies for pr
ENGLEWOOD, Colo., June 17, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflam
